CLINICAL_TRIALS
trial_result
· 2021-05-11
Clinical Trial Update: Role of Intravitreal Aflibercept Injection for the Treatment of Radiation Maculopathy [Phase 2]
Summary
Phase 2 trial update evaluating intravitreal aflibercept for radiation-induced maculopathy; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Larkin Community Hospital | Conditions: Adverse Effect of Radiation Therapy | Phase 2 | Status: COMPLETED | Results posted: 2021-05-11